glp-1 agonists pill 6 Things to Know About the New Weight Loss The SELECT trial's results, published

In addition, the SUMMIT trial evaluates the effect of tirzepatide (the GLP-1/GIP dual receptor agonist) in people with obesity-related HFpEF (Clinicaltrials.gov ID NCT04847557)

The critical component in these weight-loss drugs is GLP-1 insulin, a hormone initially used to treat diabetes due to its ability to lower blood sugar levels

Historical data shows 60-68% of medical necessity denials are overturned or reversed by plans before IMR completes

Conversations about metformins role in 2026 are shifting toward outcomes beyond glycemic control

Semin Nephrol 36(4):319330

In patients with type 2 diabetes, however, this balance breaks down